Projecting pharmaceutical expenditure in EU5 to 2021: adjusting for the impact of discounts and rebates
Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expenditure—driven by high prices—will be unsustainable unless further reforms are enacted.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
7 August 2018
|
| In: |
Applied health economics and health policy
Year: 2018, Jahrgang: 16, Heft: 6, Pages: 803-817 |
| ISSN: | 1179-1896 |
| DOI: | 10.1007/s40258-018-0419-1 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40258-018-0419-1
|
| Verfasserangaben: | Jaime Espin, Michael Schlander, Brian Godman, Pippa Anderson, Jorge Mestre-Ferrandiz, Isabelle Borget, Adam Hutchings, Steven Flostrand, Adam Parnaby, Claudio Jommi |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1693804336 | ||
| 003 | DE-627 | ||
| 005 | 20241223012249.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200402s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40258-018-0419-1 |2 doi | |
| 035 | |a (DE-627)1693804336 | ||
| 035 | |a (DE-599)KXP1693804336 | ||
| 035 | |a (OCoLC)1341313441 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Espin, Jaime |e VerfasserIn |0 (DE-588)1207474614 |0 (DE-627)169380252X |4 aut | |
| 245 | 1 | 0 | |a Projecting pharmaceutical expenditure in EU5 to 2021 |b adjusting for the impact of discounts and rebates |c Jaime Espin, Michael Schlander, Brian Godman, Pippa Anderson, Jorge Mestre-Ferrandiz, Isabelle Borget, Adam Hutchings, Steven Flostrand, Adam Parnaby, Claudio Jommi |
| 264 | 1 | |c 7 August 2018 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.04.2020 | ||
| 520 | |a Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expenditure—driven by high prices—will be unsustainable unless further reforms are enacted. | ||
| 700 | 1 | |a Schlander, Michael |d 1959- |e VerfasserIn |0 (DE-588)1036904652 |0 (DE-627)751411957 |0 (DE-576)389587710 |4 aut | |
| 700 | 1 | |a Godman, Brian |e VerfasserIn |0 (DE-588)1084653958 |0 (DE-627)848636600 |0 (DE-576)456594396 |4 aut | |
| 700 | 1 | |a Anderson, Pippa |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Mestre Ferrándiz, Jorge |e VerfasserIn |0 (DE-588)171863518 |0 (DE-627)328181102 |0 (DE-576)132622858 |4 aut | |
| 700 | 1 | |a Borget, Isabelle |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hutchings, Adam |e VerfasserIn |4 aut | |
| 700 | 1 | |a Flostrand, Steven |e VerfasserIn |4 aut | |
| 700 | 1 | |a Parnaby, Adam |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jommi, Claudio |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Applied health economics and health policy |d [Erscheinungsort nicht ermittelbar] : Springer International, 2004 |g 16(2018), 6, Seite 803-817 |h Online-Ressource |w (DE-627)481906118 |w (DE-600)2180637-8 |w (DE-576)313702640 |x 1179-1896 |7 nnas |a Projecting pharmaceutical expenditure in EU5 to 2021 adjusting for the impact of discounts and rebates |
| 773 | 1 | 8 | |g volume:16 |g year:2018 |g number:6 |g pages:803-817 |g extent:15 |a Projecting pharmaceutical expenditure in EU5 to 2021 adjusting for the impact of discounts and rebates |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s40258-018-0419-1 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20200402 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1036904652 |a Schlander, Michael |m 1036904652:Schlander, Michael |p 2 | ||
| 999 | |a KXP-PPN1693804336 |e 3617486592 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"title":"Applied health economics and health policy","title_sort":"Applied health economics and health policy"}],"pubHistory":["Nachgewiesen 3.2004 - 5.2006; 6.2008 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 23.04.14"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"year":"2018","issue":"6","volume":"16","pages":"803-817","text":"16(2018), 6, Seite 803-817","extent":"15"},"origin":[{"dateIssuedDisp":"2004-","dateIssuedKey":"2004","publisher":"Springer International ; Adis International ; Adis","publisherPlace":"[Erscheinungsort nicht ermittelbar] ; Auckland ; [Erscheinungsort nicht ermittelbar]"}],"id":{"zdb":["2180637-8"],"issn":["1179-1896"],"eki":["481906118"]},"disp":"Projecting pharmaceutical expenditure in EU5 to 2021 adjusting for the impact of discounts and rebatesApplied health economics and health policy","recId":"481906118"}],"note":["Gesehen am 02.04.2020"],"name":{"displayForm":["Jaime Espin, Michael Schlander, Brian Godman, Pippa Anderson, Jorge Mestre-Ferrandiz, Isabelle Borget, Adam Hutchings, Steven Flostrand, Adam Parnaby, Claudio Jommi"]},"recId":"1693804336","id":{"doi":["10.1007/s40258-018-0419-1"],"eki":["1693804336"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"7 August 2018"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"15 S."}],"language":["eng"],"person":[{"display":"Espin, Jaime","given":"Jaime","role":"aut","family":"Espin"},{"display":"Schlander, Michael","family":"Schlander","given":"Michael","role":"aut"},{"family":"Godman","given":"Brian","role":"aut","display":"Godman, Brian"},{"given":"Pippa","role":"aut","family":"Anderson","display":"Anderson, Pippa"},{"display":"Mestre Ferrándiz, Jorge","role":"aut","given":"Jorge","family":"Mestre Ferrándiz"},{"display":"Borget, Isabelle","family":"Borget","role":"aut","given":"Isabelle"},{"role":"aut","given":"Adam","family":"Hutchings","display":"Hutchings, Adam"},{"display":"Flostrand, Steven","given":"Steven","role":"aut","family":"Flostrand"},{"display":"Parnaby, Adam","family":"Parnaby","given":"Adam","role":"aut"},{"role":"aut","given":"Claudio","family":"Jommi","display":"Jommi, Claudio"}],"title":[{"subtitle":"adjusting for the impact of discounts and rebates","title":"Projecting pharmaceutical expenditure in EU5 to 2021","title_sort":"Projecting pharmaceutical expenditure in EU5 to 2021"}]} | ||
| SRT | |a ESPINJAIMEPROJECTING7201 | ||